SCHWARTZ MARK N 4
4 · HYPERTENSION DIAGNOSTICS INC /MN · Filed Jan 5, 2005
Insider Transaction Report
Form 4
SCHWARTZ MARK N
DirectorCEO
Transactions
- Purchase
Common Stock
2004-12-30$0.18/sh+100,000$18,000→ 100,000 total
Holdings
- 6,656
Series A Preferred Stock
→ Common Stock (6,656 underlying) - 6,656
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (6,656 underlying) - 203,559
Common Stock
- 20,480
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (20,480 underlying) - 203,558
Common Stock Warrant (right to buy)
→ Common Stock (203,558 underlying) - 325,694
Common Stock Warrant (right to buy)
→ Common Stock (325,694 underlying) - 17,920
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (17,920 underlying) - 84,681
Common Stock Warrant (right to buy)
→ Common Stock (84,681 underlying) - 74,096
Common Stock Warrant (right to buy)
→ Common Stock (74,096 underlying) - 12,800
Series A Preferred Stock
→ Common Stock (12,800 underlying) - 105,851
Common Stock Warrant (right to buy)
→ Common Stock (105,851 underlying) - 5,325
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (5,325 underlying) - 4,660
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (4,660 underlying) - 512,968
Common Stock
- 284,982
Common Stock Warrant (right to buy)
→ Common Stock (284,982 underlying) - 25,600
Series A Preferred Stock
→ Common Stock (25,600 underlying) - 12,800
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (12,800 underlying)
Footnotes (2)
- [F1]Previously reported.
- [F2]The issuer's expiration date for the exercise of the A-1 Preferred Stock Warrant and A-2 Common Stock Warrant was extended to March 15, 2005 per the Form 8-K filed on November 12, 2004.